Decades of research elucidating the pathophysiology of diabetic neuropathy have failed, thus far, to produce a treatment that prevents or reverses its development and progression. Recently ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Case 1 emphasizes the fact that a vascular pathogenesis in diabetic neuropathy cannot be excluded because clinical evidence of peripheral vascular disease is lacking.

The epidemiology, classification, pathology, and treatment of diabetic neuropathy are reviewed.

OBJECTIVES There is evidence that the polyol pathway is involved in the pathogenesis of diabetic neuropathy. Aldose reductase (ALR2) is the first and rate limiting enzyme of this pathway and recent ...

Integrated transcriptomic, proteomic, and metabolomic analysis unveils key roles of protein and nucleic acid interactions in diabetic ulcer pathogenesis ...

Understand how a combined therapy shows significant nerve and glucose improvements in diabetic neuropathy, without added safety risks.

Dapagliflozin plus methylcobalamin improved nerve function and glucose control in diabetic neuropathy.

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN) bombed, Helixmith has started dosing patients in a new study. The South ...

The early signs of type 2 diabetes can include extreme thirst, extreme hunger, and frequent urination. Learn more about other early warning signs.

The prevalence of diabetes is increasing worldwide; however, its impact on routine daily activities is often underappreciated ...